| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.007 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.088 | 0.006 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.087 | 0.004 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.004 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.098 | 0.002 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |